Shopping Cart
- Remove All
- Your shopping cart is currently empty
(Z)-SU14813 is a novel tyrosine kinase inhibitor with anticardiogenic and antitumor activity that inhibits VEGFR-2, PDGFR-β, and FLT3 phosphorylation in xenograft tumors in a dose- and time-dependent manner.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $195 | In Stock | |
5 mg | $483 | In Stock | |
10 mg | $692 | In Stock | |
25 mg | $1,080 | In Stock | |
50 mg | $1,490 | In Stock | |
100 mg | $1,970 | In Stock |
Description | (Z)-SU14813 is a novel tyrosine kinase inhibitor with anticardiogenic and antitumor activity that inhibits VEGFR-2, PDGFR-β, and FLT3 phosphorylation in xenograft tumors in a dose- and time-dependent manner. |
In vivo | METHODS: (Z)-SU14813 was evaluated in mouse tumor efficacy studies in C6 rat glioma (20, 40 mg/kg) and MV4 11 human AML (10, 20, 40 mg/kg) mouse models. RESULTS: (Z)-SU14813 treatment of C6 rat glioma model mice was sufficient to produce complete anti-tumor efficacy; (Z)-SU14813 treatment of MV4 11 human AML model increased mouse survival time from 23 days to 42 days. [1] |
Molecular Weight | 442.48 |
Formula | C23H27FN4O4 |
Cas No. | 452105-23-6 |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.